<DOC>
	<DOCNO>NCT01394029</DOCNO>
	<brief_summary>This study observe patient transfusional hemosiderosis treat deferasirox actual practice setting .</brief_summary>
	<brief_title>Observation Patients With Transfusional Hemosiderosis Treatment With Deferasirox</brief_title>
	<detailed_description />
	<mesh_term>Hemosiderosis</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>Patients treat deferasirox transfusional hemosiderosis accord local prescribing information . ( patient either begin treatment deferasirox time enrollment sentinel site monitor currently treatment deferasirox start treatment prescription twelve month prior enrollment sentinal site monitoring . Patients nontransfusional hemosiderosis Patients treat deferasirox interventional clinical trial Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>iron overload</keyword>
	<keyword>iron chelation</keyword>
	<keyword>deferasirox</keyword>
	<keyword>observational</keyword>
</DOC>